Form 4: Thermo Fisher Scientific Executive Vice President Frederick M. Lowery Reports Stock Transactions
SEC Form 4
Executive Vice President Frederick M. Lowery of Thermo Fisher Scientific reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Frederick M. Lowery, an Executive Vice President at Thermo Fisher Scientific, reported transactions involving the company's common stock on February 24, 2025.
- Lowery exercised stock options to acquire 18,300 shares at a price of $210.68 per share.
- Simultaneously, Lowery sold 18,300 shares at $531.81 per share.
- Following these transactions, Lowery directly owns 16,954.0064 shares of Thermo Fisher Scientific common stock.
- Lowery also indirectly owns 1,146.39 shares through a 401K and 5.036 shares through a Limited Liability Company.
- The transactions were executed under a Rule 10b5-1 trading plan adopted on September 9, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports routine stock transactions by an executive under a pre-arranged trading plan. There's no indication of positive or negative sentiment towards the company's prospects.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, suggesting they were planned well in advance and not based on any recent inside information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are a common tool used by executives to sell shares in a pre-planned manner, avoiding concerns about insider trading.
- The vesting schedule of the options is typical, with vesting occurring over several years to incentivize long-term performance.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are part of a pre-arranged trading plan and do not reflect a change in the company's fundamentals.
Key Dates
| Date | Description |
|---|---|
| 09/09/2024 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 02/27/2019 | First vesting date of the stock option. |
| 02/27/2020 | Second vesting date of the stock option. |
| 02/27/2021 | Third vesting date of the stock option. |
| 02/27/2022 | Fourth vesting date of the stock option. |
| 02/24/2025 | Date of the reported transactions: exercising stock options and selling shares. |
| 02/26/2025 | Date of the Form 4 filing. |
| 02/27/2025 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.